项目 | 对照组 | 试验I组 | 试验II组 | 试验III组 |
37日龄 |
|
|
|
|
超氧化物歧化酶(SOD)(U/L) | 164.54 ± 6.15 | 166.05 ± 8.21 | 168.98 ± 15.76 | 167.04 ± 5.92 |
谷胱甘肽-过氧化物酶(GSH-PX)(U/L) | 600.47 ± 46.80 | 606.62 ± 51.94 | 608.75 ± 38.85 | 621.46 ± 22.71 |
过氧化氢酶(CAT)(U/L) | 50.05 ± 6.58 | 48.15 ± 5.71 | 50.94 ± 3.86 | 48.42 ± 2.18 |
总抗氧化能力(TAOC) | 6.67 ± 0.28 | 6.47 ± 0.37 | 6.50 ± 0.26 | 6.68 ± 0.60 |
44日龄 |
|
|
|
|
超氧化物歧化酶(SOD)(U/L) | 166.16 ± 17.44 | 172.98 ± 15.51 | 174.47 ± 6.26 | 178.33 ± 7.34 |
谷胱甘肽-过氧化物酶(GSH-PX)(U/L) | 615.51 ± 24.34 | 638.67 ± 32.43 | 616.75 ± 28.21 | 632.19 ± 33.12 |
过氧化氢酶(CAT)(U/L) | 51.82 ± 2.79 | 50.54 ± 3.71 | 52.09 ± 1.24 | 51.75 ± 3.79 |
总抗氧化能力(TAOC) | 6.72 ± 0.25 | 6.63 ± 0.32 | 6.62 ± 1.07 | 6.78 ± 0.30 |
51日龄 |
|
|
|
|
超氧化物歧化酶(SOD)(U/L) | 169.46 ± 6.96 | 178.17 ± 17.92 | 176.94 ± 2.51 | 179.58 ± 14.86 |
谷胱甘肽-过氧化物酶(GSH-PX)(U/L) | 632.62 ± 20.38 | 640.56 ± 30.91 | 658.30 ± 35.11 | 673.32 ± 44.29 |
过氧化氢酶(CAT)(U/L) | 51.93 ± 1.81 | 52.5 ± 2.16 | 51.31 ± 2.90 | 51.1 ± 5.30 |
总抗氧化能力(TAOC) | 6.79 ± 0.34 | 6.77 ± 0.22 | 6.79 ± 0.50 | 7.21 ± 0.32 |